ATG Interviews Moshe Pritsker, CEO and Co-Founder, JoVE by Strauch, Katina
Against the Grain
Volume 22 | Issue 6 Article 18
December 2010
ATG Interviews Moshe Pritsker, CEO and Co-
Founder, JoVE
Katina Strauch
Against the Grain, strauchk@cofc.edu
Follow this and additional works at: https://docs.lib.purdue.edu/atg
Part of the Library and Information Science Commons
This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.
Recommended Citation
Strauch, Katina (2010) "ATG Interviews Moshe Pritsker, CEO and Co-Founder, JoVE," Against the Grain: Vol. 22: Iss. 6, Article 18.
DOI: https://doi.org/10.7771/2380-176X.5696
49Against	the	Grain	/	December	2010	-	January	2011	 <http://www.against-the-grain.com>			
continued on page 50
ATG Interviews Moshe Pritsker
CEO, Co-Founder, Journal of Visualized Experiments – JoVE
by Katina Strauch  (Editor, Against the Grain)  <kstrauch@comcast.net>
ATG:	 	 Moshe,	 tell	 us	 about	 JoVE,	 the	
Journal	 of	 Visualized	 Experiments.	 	 We	
understand	that	it	is	a	video	journal	for	bio-
logical	research.
MP:  JoVE has created a new video-based 
concept of scholarly publishing.  In this 
concept, a scientific journal article has two 
principle components, video and text.  The 
video provides a step-by-step demonstration 
of research procedures and methods employed. 
Since “a picture is worth a thousand words,” 
such video-articles enable more efficient 
knowledge transfer than traditional text-only 
articles, allowing much faster learning for end 
users, scientists, and students. 
Despite its innovative format, JoVE acts 
as a rigorous scientific journal, having a pres-
tigious Editorial Board, employing review 
processes, and being indexed in PubMed and 
MEDLINE.  To summarize, JoVE is the first-
in-the-world video journal for biological and 
biomedical sciences.
In the end, JoVE aims to make a revolution 
in science and STM publishing industry to 
convert publication into a productivity tool that 
can be used to rapidly transfer new knowledge 
and technologies.  This will save a lot of time 
and money for scientists, educators, and their 
institutions.
ATG:		What	led	you	to	create	this	format?	
What	 sort	 of	 acceptance/take	 up	 have	 you	
been	 experiencing?	 	 What	 is	 the	 current	
subscription	price	for	a	year?
MP:  I came to this idea because of my 
personal experience as a research student in 
biology, during my Ph.D. studies at Princ-
eton.  For laboratory scientists, it is very, very 
difficult to learn new experimental methods 
and technologies based on their description in 
traditional text-based science journals.  This 
is because the text format cannot provide 
an adequate description of numerous details 
important for accomplishing a particular 
experiment.  So scientists spend a lot of their 
time (months) and grant money “reinventing 
the wheel,” when they have to re-learn experi-
ments already done and described 
by others.  The practical solution to 
this problem typically employed in 
labs is to find another scientist who 
is familiar with specific methods 
employed and who can show how 
to apply them.  But often such a 
help is not available, and scientists 
are forced to repeat the experiment 
again and again until it begins 
to work.  This is a well known 
“bottleneck” problem of productiv-
ity in biological sciences, and every 
practicing biological researcher is 
aware of it. 
Doing my Ph.D. thesis research and suf-
fering from this problem, I asked myself a 
question: “What will be a systematic solution 
for this problem?”.  I realized that an ideal 
solution would be to mimic the “show me” 
solution and produce videos demonstrating 
every possible biological experiment.  I also 
realized this solution should be presented as a 
journal, and not just a database or Website, to 
provide scientists with an incentive to partici-
pate in this project.  This is because academic 
scientists care mostly about two things, grant 
money and their publications in scientific 
journals — “publish or perish,” as we know 
this academic phenomenon.  If so, video would 
become a science article of a new type.  So the 
idea of JoVE was born.
I co-founded JoVE with my two partners, 
Nikita Bernstein and Klaus Korak.  Nikita 
is the company CTO, and he did all the Web 
development to build the JoVE Website.  Klaus 
was the first investor and he recruited further 
investments to finance the company opera-
tions.  I should mention other people, JoVE 
employees, who strongly contributed to the 
company growth at first stages:  Aaron Kolski-




MP:  The video-production presented a 
significant challenge we had to overcome.  As 
JoVE was started, we realized 
it is very difficult to make a 
video on biological experiment. 
It requires special equipment, 
software, skills for filming and 
editing that scientists typically 
do not have.  Therefore scientists 
cannot produce good videos on 
their own experiments.  This 
means that JoVE has to produce 
these videos for them in their 
labs.  For this purpose, we estab-
lished an international network 
of filming professionals, selected 
and trained to film videos in labo-
ratories at scientific institutions 
around the world.  This network 
now covers 12 countries including USA, 
Canada, UK, Germany, Sweden, Switzerland, 
Israel, and Australia.  To maintain the current 
publication rate, we produce 40 videos per 
month.  We worked hard to make this process 
manageable and cost-effective, yet it should 
be noted that the production costs per article 
are much higher for JoVE than for traditional 
text-only publishers since we have to pay the 




MP:  Since its foundation in the end of 
2006, JoVE has published over 750 video-
articles describing research methodologies 
in different areas of biological sciences such 
as neuroscience, developmental biology, 
microbiology, immunology, stem cells, bioen-
gineering, and others.  Most of these articles 
are produced at leading academic institutions 
in the USA and Europe such as Harvard, 
MIT, Yale, Stanford, Yale, NIH, Berkeley, 
Oxford (UK), Cambridge (UK), Max Planck 
Institute (Germany), Weizmann Institute 
(Israel), and others. 
With respect to the subscription pricing 
structure, we divide institutions to three tiers: 
Ph.D. level (first tier), M.Sc. level (second 
tier), and B.Sc. level (third tier).  The Ph.D. 
level institutions include universities granting 
Ph.D. degrees and research institutes.  Colleges 
are typically included in the B.Sc. level tier. 
In 2009-2010, the subscription price for Ph.D. 
level institutions was $2,400 per year. 
This year, receiving numerous requests 
from scientists and students, we have increased 
our publication rate and established two new 
sections, JoVE Neuroscience and JoVE Im-
munology & Infection.  We offer these new 
sections for subscription in 2011, so for Ph.D. 
level institutions the total price for the three-
section package is $7,200, if subscribed before 
January 1, 2011.  The price will be higher after 
this date, as we try to attract early adopters to 
subscribe as soon as possible so we can use the 
funds to further increase our publication rate. 
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Our prices are significantly lower for M.Sc. 
and B.Sc. level institutions. 
Currently, nearly 200 institutions are sub-
scribed to JoVE, including such world leaders 
in research and education as Harvard, MIT, 
NIH, Stanford, Yale, UC Berkeley, Princ-
eton, and others.  Overall, the list of subscribers 





MP:  The JoVE peer review is very similar 
to the peer-review process in traditional text 
journals.  A video article is sent to three anony-
mous reviewers who then provide their com-
ments on the video and text part of each article. 
For example, they can say “I have a problem 
with this specific procedure at 3 minute 5 sec-
ond from the beginning of the video.” 
ATG:  How is this financed?  Did you 
obtain	a	grant?		How	will	JoVE	be	supported	
in	the	future?
MP:  After its foundation in the end of 
2006, JoVE was financed through an “angel” 
investment received from a group of private in-
vestors in Switzerland, Germany, and Austria. 
As its operations grew, JoVE has implemented 
a business model, which is very similar to the 
models employed by other STM publishers. 
The revenues come from author fees, institu-
tional subscriptions, and sponsorships from 
companies.  JoVE became profitable at the end 
of 2009, and continues to grow.
The main difference between JoVE and 
other STM publishers is the high cost of video 
production which makes JoVE articles much 
more expensive to produce.  We have to care-
fully walk the thin line between keeping our op-
erations sustainable and keeping our subscrip-
tion fees acceptable to institutions, especially 




MP:  Sponsored articles means articles 
where video-production fees are sponsored 
by biotech companies, producers of research 
tools.  They are peer reviewed too, of course. 
A disclaimer on sponsorship is included for 
such articles.
ATG:	 	 How	 is	 JoVE	 indexed	 or	 made	
available	in	the	wider	Internet	community?	
Is	 it	 indexed	by	ISI	or	will	 it	be	considered	
for	indexing	there?
MP:  JoVE is indexed in MEDLINE/
PubMed and Chemical Abstracts/Scifinder. 
We are considering an application to ISI.
ATG:	 	 This	 is	 an	 innovative	 and	 “next	
generation”	publication.		What	other	similar	
types	of	endeavors	are	you	aware	of?
MP:  I do not want to sound arrogant but I 
did not hear about any other significant recent 
developments with respect to the format of 
scientific articles.  In general, with respect 
to the principal format, the STM publishing 
did not change much since the publication 
of the first scientific articles in the 17th 
century.  Yes, science literature content was 
transferred to the Internet, but the nature of 
the articles remains the same — these are 
poorly structured text descriptions that are 
full of technical terms, understandable only 
to specialists in specific narrow fields, and 
difficult to use even for these specialists.  At 
this moment, we see some first attempts by 
STM publishers to experiment with changes 
in the traditional text-based format.  For 
example, the journal Cell (published by 
Elsevier) works on the project called “Ar-
ticle of the Future” to integrate more visual 
information in its articles.  But such attempts 
are still very rare.
So far, the important changes happened 
in the way we organize and use the scien-
tific literature.  Creation of PubMed by 
the National Library of Medicine (NLM) 
was a true revolution, in my opinion.  NLM 
continues to lead integrating PubMed with 
Genbank and other resources changing us-
age patterns and creating totally new expe-
riences for scientists and students.  Linking 
and cross-referencing was very helpful, too. 
The “author-pay” business model promoted 
by the Open Access movement was an inter-
esting development.  However, again, these 
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CEO, Co-founder, Journal of Visualized Experiments (JoVE) 
48 Grove Street, Suite 305, Somerville MA  02144 
Phone:  (617) 996-5363  •  Fax:  (866) 381-2236 
<moshe.pritsker@jove.com>  •  www.jove.com
Born and lived:  Born in Russia, immigrated to Israel at age 16, came to U.S. 
as a Ph.D. student at age 26.  For those who don’t know, “Moshe” is the Hebrew 
version of “Moses.”
early life:  I was born in the city named Petrozavodsk, which is the North-West 
part of the Soviet Union.  I had a normal life of a normal Soviet school child.  In 
1990, at the age 16, I immigrated to Israel together with my parents, in the big 
wave of Russian-Jewish immigration.  I went to study chemistry at the Hebrew 
University of Jerusalem, and then continued for a master degree at the Weizmann 
Institute of Science.  After the army service mandatory for every Israeli citizen, I 
decided to see the world and got into the Ph.D. program at Princeton, NJ.
professional career and activities:  I got a Ph.D. in Molecular Biology 
from princeton University and a M.Sc. in Chemistry from the Weizmann institute 
of science.  I worked in a few research areas such as stem cells, genomics, bio-
informatics, and HIV.  The results of my research were published in well-known 
scientific journals (PNAS, JBC, Genome Research and Biochemistry).  For one 
year, I was working as a post-doctoral researcher at the Massachusetts General 
Hospital, affiliated with Harvard Medical school.  Then I started JoVE.
faMily:  Single.
in My spare tiMe i like to:  Read, watch movies.
favorite Books:  Many.  The last I read – Predictable Irrationality by dan 
ariely. 
pHilosopHy:  Work hard, life is short.
Most MeMoraBle career acHieveMent:  First article published in a scientific 
journal (PNAS) and the indexing of JoVE in pubMed
Goal i Hope to acHieve five years froM noW:  Grow JoVE big, make it 
even more useful.
HoW/WHere do i see tHe indUstry in five 
years:  I think the STM publishing industry 
will mainly remain the same because I do not 
envision any viable alternatives to its current 
business model or any significant changes in the 
workflows/incentives governing the behavior of 
end users, scientists, and students.  Significant 
changes, if they happen, will be generated by 
technological developments such as the spread 
of mobile devices, quality product improvements 
(e.g., video), or changes in the economics of 
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changes did not affect the principal structure and format of the sci-
entific article, and this is where JoVE wants to make a difference.
A number of new initiatives were made in the scientific community 
information space.  For example, there were a few attempts to create 
science-oriented Facebook-like social network sites (e.g., Epernicus.
com and Labmeeting.com) and YouTube-like community video sites 
(e.g., SciVee.tv and DNAtube.com). We are yet to see how much these 
initiatives will be adopted by the scientific community.
From my experience, to be adopted, any new offering in science 
communication has to align with current professional incentives of 
scientists and students: getting grants, publishing in scientific jour-
nals, finding the next job, or receiving better grades.  Otherwise, it 
will not work.
ATG:		Please	speculate	on	the	future	for	the	journal.
MP:  I am optimistic since the JoVE receives more and more ac-
ceptance among scientists, students, and librarians.  We will expand 
by increasing the scope and rate of the video publication.  Specifically, 
we plan to establish new JoVE sections for major areas of biomedical 
research such as Oncology and Bioengineering, in addition to Neurosci-
ence and Immunology that are being built now.  We should consider 
expanding to other areas such as Psychology.
I think that sooner or later, following the JoVE growth, big STM 
publishers will try to massively integrate online video into their prod-
ucts, although it will require significant technology developments and 
organizational changes on their part.  From this point of view, JoVE 
serves as a pioneer and a catalyst of change for the entire industry. 
In the end, video will become an important component of the STM 
publishing.  
enhanced reading.  We will see sentences from many different articles 
brought together.” This is the power of the computer technology.  Still, 
the artifact must remain for future generations.
http://www.katina.info/conference/video_2010_trust.php
Which brings me to the word “stewardship.”  I only took note of two 
Plenary speakers using that word during the 30th Charleston Confer-
ence.  The first was Brian Schottlaender who made stewardship the 
centerpiece of his talk – Full Spectrum Stewardship of the Scholarly 
Record.  And the second was Jon Orwant from Google Books.  Stew-




Speaking of which – did you hear Jon Orwant’s (Engineering Man-
ager, Google Books) talk at the 30th Charleston Conference this past 
year?  It was Friday afternoon late and it was fascinating!  The auditori-
ums were packed even though it was 5:30 to 6:15 on Friday!  Jon says 
that he estimates that you can read 7,000 books in your lifetime.  That’s 
a lot of Kindle and Nook and iPad purchases!
http://www.katina.info/conference/video_2010_orwant.php
Welcome to the circumspect Alex Holzman (did you see him in Charles-
ton?) who is the new editor of the University Press column in ATG!  Bringing 
up words and all, I was interested in the column in this issue, p.61, by Richard 
Brown which talks about the need for librarian/university press collaboration, 
REAL collaboration.  Brown points to the use of casual metaphors (e.g., 
university press as dinosaur, printed books as relics).  He urges that we be 
more careful with our language.   Books/Words are more than bits and bytes. 
They are expressions of an author’s/writer’s/groups’ thoughts. 
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